Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
IOL Chemicals & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524164NSE Symbol: IOLCPP/E(TTM):20.54
ISIN Demat:INE485C01011Div & Yield %:1.46EPS(TTM):16.62
Book Value(Rs):282.5638902Market Cap ( Cr.):2004.21Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 2132.792217.112184.021966.981894.471685.33
Excise Duty0.000.000.000.000.000.00
Net Sales2132.792217.112184.021966.981894.471685.33
Other Income 30.0725.5732.0424.3016.0210.37
Stock Adjustments 38.2518.2052.3017.11-20.96-51.31
Total Income2201.112260.882268.362008.391889.531644.39
EXPENDITURE :      
Raw Materials 1435.201565.291622.811119.951044.05995.94
Power & Fuel Cost149.05131.9878.1851.4665.1263.94
Employee Cost 201.02168.21141.30115.5597.2078.43
Other Manufacturing Expenses 47.6743.0736.8628.1328.3725.68
Selling and Administration Expenses 60.2468.3771.9655.2651.3139.88
Miscellaneous Expenses 46.3431.8742.8621.9013.5820.50
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1939.522008.791993.971392.251299.631224.37
Operating Profit261.59252.09274.39616.14589.90420.02
Interest 16.1016.478.295.8320.9351.42
Gross Profit245.49235.62266.10610.31568.97368.60
Depreciation62.8546.1343.2638.9235.7332.45
Profit Before Tax182.64189.49222.84571.39533.24336.15
Tax37.0146.2657.01145.55170.9029.38
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax10.213.250.17-18.721.0570.07
Reported Net Profit135.42139.98165.66444.56361.29236.70
Extraordinary Items 0.07-0.27-11.05-0.050.00-0.01
Adjusted Net Profit135.35140.25176.71444.61361.29236.71
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward1218.231101.75971.31550.23209.51-27.19
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 29.3523.5035.2223.4820.570.00
P & L Balance carried down1324.301218.231101.75971.31550.23209.51
Dividend29.3523.5035.2223.4817.070.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0040.0040.0060.0030.000.00
Earnings Per Share-Unit Curr23.0723.8428.2275.7263.5141.61
Earnings Per Share(Adj)-Unit Curr23.0723.8428.2275.7263.5141.61
Book Value-Unit Curr274.46256.61236.80214.69141.3681.74